Viewing nowLipinon Tablets 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Trihydrate 20.72mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

MFDS item code 200704961 · Notified 2007.04.30 · Insurance code 642500640
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medicine helps reduce the risk of cardiovascular diseases. It lowers the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease or in patients with type 2 diabetes. Additionally, it reduces the risk of hospitalization due to revascularization, angina, and congestive heart failure, improving cardiovascular health. It is also effective in treating hyperlipidemia by lowering total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels while raising HDL cholesterol levels. It is used in conjunction with dietary management to lower cholesterol levels in pediatric patients with familial hypercholesterolemia. Therefore, this medicine is widely used for reducing the risk of cardiovascular disease and treating dyslipidemia.
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is atorvastatin 10 mg once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of more than 45 % is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into account treatment goals and response. Analyze lipid levels within 2 ~ 4 weeks of starting treatment and/or adjusting the dose, and adjust the dose accordingly. Since the treatment goal is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol may be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia: The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. Elderly patients: Efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult patient population.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medicine may cause muscle problems, so if symptoms such as muscle pain or weakness occur, notify a doctor immediately. If there is a significant increase in creatine kinase levels or suspicion of myopathy, discontinuation of the drug should be considered. Patients with poor liver function or active liver disease should not take this medicine. Pregnant or breastfeeding women should not take this medicine. Children under 10 years of age should not use this medicine, while adolescents over 10 years should take it under the direction of a physician. Caution is needed for patients with a history of alcohol abuse, liver disease, or poor kidney function when taking this medicine. This medicine may interact with other medications, so consult a doctor if taking it with specific antibiotics, antifungals, HIV treatments, colchicine, or nicotinic acid. It is important to have regular liver function tests and muscle-related tests while taking this medication. If a rash, itching, hives, or severe allergic reactions occur, discontinue use immediately and inform a doctor. Women taking this medicine should use appropriate contraceptive methods and discontinue use immediately if pregnancy is confirmed. There is no specific antidote for overdose; therefore, treatment should be provided according to symptoms, and liver function and muscle condition should be monitored. Keep this medicine out of reach of children, and store it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medicine may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius to safely preserve the medicine’s effectiveness.
This medicine is a white oval film-coated tablet.
300 tablets/bottle, 30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 20.72mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.